NUCRYST Pharmaceuticals Corp.
Healthcare · Surgical & Medical Instruments & Apparatus · A0 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Modified shareholder rights · Director / officer changeFeb 10, 2010
- Completed an acquisition or dispositionDec 29, 2009
- Director / officer changeDec 21, 2009
- Other material eventNov 25, 2009
- Entered a material agreementNov 17, 2009
- Results of operationsNov 16, 2009
- Delisting / listing-standard noticeSep 21, 2009
- Other material eventSep 3, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15Feb 18, 2010
- 8-KFORM 8-KFeb 10, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8Feb 8, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8Feb 8, 2010
- SC 13E3/ASCHEDULE 13E-3/AFeb 8, 2010
- 25-NSEFeb 8, 2010
- SC 13E3/ASCHEDULE 13E-3/AJan 15, 2010
- CORRESPJan 7, 2010
- UPLOADJan 4, 2010
- 8-KFORM 8-KDec 29, 2009
- CORRESPDec 28, 2009
- UPLOADDec 23, 2009
- 8-KFORM 8-KDec 21, 2009
- SC 13E3Dec 1, 2009
- 8-KFORM 8-KNov 25, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.